Breaking the Bottleneck: Rethinking Study Start-Up for Faster Trial Activation

About this episode

This episode discusses the persistent bottlenecks in clinical trial study start-up and features insights from industry experts.

Study start-up remains one of the most persistent bottlenecks in clinical trials—slowing site activation, delaying patient enrollment, and adding pressure across already stretched teams. In this episode of WCG Talks Trials, host Jamie Harper, Vice President of Site Solutions & Engagement at WCG, is joined by Stephanie Held, Associate Director of Coverage Analysis, and Jody Ingebritsen‑Howe, Director of Contracts & Budgets, to unpack why start-up timelines continue to stall and w...

People in this episode

Host: Jamie Harper

Guests: Stephanie Held, Jody Ingebritsen‑Howe

Topics covered

• clinical trials
• study start-up
• site activation
• patient enrollment
• team pressure

Keywords

• clinical trials
• study start-up
• site activation
• patient enrollment
• WCG

Mentioned in this episode

Organizations: WCG